ANI 793 Pill - red capsule/oblong
Pill with imprint ANI 793 is Red, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 54 mg. It is supplied by Halo Pharmaceutical.
Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 54 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for ANI 793
Methylphenidate Hydrochloride Extended-Release
- Imprint
- ANI 793
- Strength
- 54 mg
- Color
- Red
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Halo Pharmaceutical
- Manufacturer
- ANI Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 62559-0793
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,065)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
- Methylphenidate drug information
- Methylphenidate transdermal
- Methylphenidate (Oral) (Advanced Reading)
- Methylphenidate (Transdermal) (Advanced Reading)
- Methylphenidate Chewable Tablets
Other brands
Ritalin, Concerta, Jornay PM, Ritalin LA, ... +11 more
Professional resources
- Methylphenidate monograph
- Methylphenidate CD Capsules (FDA)
- Methylphenidate Chewable Tablets (FDA)
- Methylphenidate ER Capsules (FDA)
- Methylphenidate Hydrochloride (FDA)
Other brands
Ritalin, Concerta, Jornay PM, Ritalin LA, ... +10 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
